upcoming results from clinical trials for treating relapsed, low grade lymphoma
Published 6 years ago • 125 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:43
ongoing clinical trials to look out for in lymphoma
-
7:50
updates from the lymphoma & cll session: clinical trials, novel agents, and more
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
10:41
trial updates in follicular lymphoma from ash 2019
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
0:42
upcoming trial updates in all
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
3:21
long-term outcomes from key clinical trials presented at ash 2023
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
11:43
will knowledge of the molecular pathology of lymphoma improve clinical trials?
-
0:53
evolution of the treatment landscape for patients with cns lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
7:52
highlights in t-cell lymphoma: unmet needs, clinical trial updates, and future outlooks
-
1:18
hodgkin lymphoma highlights at ash 2022 and future outlooks